To: King Systems Customers
Re: KING LT(S)-D™ Oropharyngeal Airway update
Dear Valued Customers,
As stated in our communication dated December 4, 2009, the FDA accepted our amended IFU (Instruction for Use) with the revised Indications and Contraindications (noted below) and as such we have continued shipment of product with the revised IFU and Labeling.
Please note that King Systems has taken the following actions associated with the KING LT Product:
The KLT(S)-D is not proven to protect the airway from the effects of regurgitation and aspiration. The risk of regurgitation and aspiration must be weighed against the potential benefit of establishing an airway.
The KLTS-D/KLT-D 510(k) with broader Indications for the KLT product and defined intended use for difficult and emergency airways has been submitted to the FDA. We are pursuing all avenues to expedite its review and approval.
If you have questions, please email them to ltsd@www.kingsystems.com or contact me directly at 317-776-6823, extension 257.
Tags: Anesthesia, Medical Products
Posted in
News Releases |